Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 12, 341-345, May 1, 1952]
© 1952 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Henstell, H. H.
Right arrow Articles by Freedman, R. I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Henstell, H. H.
Right arrow Articles by Freedman, R. I.

The Viscosimetric Determination of Desoxyribonuclease Inhibition*

Henry H. Henstell and Robert I. Freedman

( Institute for Medical Research, Cedars of Lebanon Hospital, Los Angeles, Calif.)

1. A viscosimetric method is described for the determination of desoxyribonuclease activity and of the desoxyribonuclease inhibitor.
2. The inhibitory activity of cell extracts is optimum at pH 6.75. At acid pH values, interaction between the inhibitor and the enzyme is prevented, but the inhibitor is not destroyed. The reaction between the inhibitor and enzyme is instantaneous and reversible.
3. Extracts of human white blood cells and bone marrow cells, in the presence of plasma, show no significant losses of inhibitor activity over a 4-7-hour period, but gradually lose their activity over a period of 24 hours or more.
4. The inhibitor content of human serum is low, about 0.4 per cent/0.001 ml, and probably arises from the white blood cells.

* Aided by a grant from the Charles R. Blakely Fund of the National Research Council.

Received 9/ 4/51.


This article has been cited by other articles:


Home page
LupusHome page
P J Lachmann
Lupus and desoxyribonuclease
Lupus, March 1, 2003; 12(3): 202 - 206.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1952 by the American Association for Cancer Research.